Obesity is a growing global health concern, leading to numerous complications such as diabetes, heart disease, and certain types of cancer. Traditional weight management strategies, including diet and exercise, often fall short for many individuals struggling with obesity. However, medical advancements have introduced new tools in the battle against obesity, one of which is Wegovy. This weight loss injection has shown significant promise in helping individuals achieve and maintain a healthier weight. In this article, we explore the role of Wegovy in managing obesity from a medical perspective. What is Wegovy? Wegovy, also known by its generic name semaglutide, is a once-weekly injection used to aid weight loss in adults who are overweight or obese. It was approved by the U.S. Food and Drug Administration (FDA) in June 2021. Wegovy belongs to a class of medications called GLP-1 receptor agonists, which are also used to manage type 2 diabetes. How Does Wegovy Work? Wegovy wor...